D.E. Shaw & Co’s Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share HIPO.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding HIPO.WS
CAC
SPC
BG
KL
CCA
LCG
SRF
D.E. Shaw & Co's HIPO.WS Position: Q3 2022 in Review
D.E. Shaw & Co sold out of Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share (HIPO.WS) in Q3 2022, closing a stake of 10,000 shares — an estimated $2K sold.
D.E. Shaw & Co first reported a position in HIPO.WS in Q3 2021 and held it in 4 quarters. The position peaked at $9K in Q3 2021. 22 funds tracked by Wall St. Rank hold HIPO.WS as of Q3 2022.
- D.E. Shaw & Co reported no remaining Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position as of Q3 2022 after selling out during the quarter.
- D.E. Shaw & Co sold 10,000 Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share shares in Q3 2022, an estimated $2K.
- D.E. Shaw & Co first reported a position in Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share in Q3 2021 and held it in 4 quarters.
- D.E. Shaw & Co's Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position peaked at $9K in Q3 2021.
- 22 funds tracked by Wall St. Rank held Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share as of Q3 2022.
Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.